4//SEC Filing
STRATTAN CE RICK 4
Accession 0001437749-23-029513
CIK 0000922247other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:05 PM ET
Size
4.7 KB
Accession
0001437749-23-029513
Insider Transaction Report
Form 4
STRATTAN CE RICK
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2023-10-27+42,599→ 271,424 total
Footnotes (1)
- [F1]Represents shares of common stock issued in lieu of cash compensation to the Reporting Person for consulting services rendered to the Issuer through September 30, 2023 valued at $40,000. The number of shares received in lieu of cash was calculated based on the closing price of $0.939 per share of the Issuer's common stock on October 27, 2023.
Documents
Issuer
Cyclo Therapeutics, Inc.
CIK 0000922247
Entity typeother
Related Parties
1- filerCIK 0000943648
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:05 PM ET
- Size
- 4.7 KB